Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

[A single-center controlled clinical study with Sandimmune Neoral after kidney transplantation].

Matl I, Vítko S, Lácha J, Horcicková M, Nosková L, Símová M, Táborský P, Viklický O, Hulínský V, Lánská V.

Vnitr Lek. 1997 Nov;43(11):703-6. Czech.

PMID:
9650498
3.

[A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].

Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.

Ann Chir. 1998;52(8):716-21. French.

PMID:
9846420
4.

Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.

Trull A, Steel L, Sharples L, Stewart S, Parameshwar J, McNeil K, Wallwork J.

Ther Drug Monit. 1999 Feb;21(1):17-26.

PMID:
10051050
5.

Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.

Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.

Transplantation. 1998 Dec 27;66(12):1632-40. Erratum in: Transplantation 1999 May 27;67(10):1386.

PMID:
9884251
6.

Experience with neoral versus sandimmune in primary liver transplant recipients.

Pinson CW, Chapman WC, Wright JK, Hunter EB, Awad JA, Raiford DS, Payne JL, Geevarghese S, Blair TK, Van Buren DH.

Transpl Int. 1998;11 Suppl 1:S278-83.

7.

Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients.

Arumugam R, Soriano HE, Scheimann AO, Reid BS, Gopalakrishna GS, Barakat O, Ozaki CF, Wood PR.

Clin Transplant. 1998 Dec;12(6):588-92.

PMID:
9850457
8.

Neoral use in the cardiac transplant recipient.

Valantine H.

Transplant Proc. 2000 May;32(3A Suppl):27S-44S. Review.

PMID:
10814748
9.

Cyclosporine formulation and Kaposi's sarcoma after renal transplantation.

Cattaneo D, Gotti E, Perico N, Bertolini G, Kainer G, Remuzzi G.

Transplantation. 2005 Sep 27;80(6):743-8.

PMID:
16210960
10.

Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.

Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.

Transpl Int. 2001 Dec;14(6):370-83.

11.

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.

Canadian Neoral Renal Transplantation Study Group.

Transplantation. 2001 Sep 27;72(6):1024-32.

PMID:
11579295
12.

NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation.

Alvarez F, Atkison PR, Grant DR, Guilbault N, Jones AB, Kim PS, Kneteman NM, Laurin L, Martin SR, Murphy GF, Paradis K, Shapiro J, Smith LJ, Superina RA.

Transplantation. 2000 Jan 15;69(1):87-92.

PMID:
10653385
13.

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.

Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP; Sirolimus Renal Function Study Group.

Transplantation. 2002 Dec 15;74(11):1560-7.

PMID:
12490789
14.

How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?

Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.

Clin Transplant. 1998 Oct;12(5):379-90.

PMID:
9787945
15.

An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral.

Pasha TM, Wiesner RH, Dahlke LM, Porayko MK, Krom RA.

Liver Transpl Surg. 1998 Sep;4(5):410-5.

16.

A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation. Italian Multicentre Study Group for Renal Transplantation (SIMTRe).

Ponticelli C, Tarantino A, Segoloni GP, Cambi V, Rizzo G, Altieri P, Mastrangelo F, Castagneto M, Salvadori M, Valente U, Cossu M, Federico S, Pisani F, Montagnino G, Messina M, Arisi L, Carmellini M, Piredda G, Corbetta G.

J Am Soc Nephrol. 1997 Apr;8(4):638-46.

17.
18.
19.

Development of Sang-35: a cyclosporine formulation bioequivalent to Neoral.

First MR, Alloway R, Schroeder TJ.

Clin Transplant. 1998 Dec;12(6):518-24.

PMID:
9850444
20.

The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients.

Goel M, Flechner SM, Ischikawa A, Induhara R, Mastroianni B, Savas K, Modlin C, Goldfarb D, Feng J, Cook DJ, Novick AC.

Clin Transplant. 2002 Dec;16(6):442-9.

PMID:
12437625

Supplemental Content

Support Center